TED-A9 Stem Cell Therapy Shows Potential for Parkinson’s Symptom Relief
TED-A9, an investigational stem cell therapy, has demonstrated safety and early signs of efficacy in a clinical trial for Parkinson’s disease. In a one-year follow-up, six treated patients showed a reduction in motor symptoms, with greater improvements observed in the high-dose group.
